Caracterización del potencial oncolítico del aislamiento rotaviral Wt1-5 en cultivos primarios de leucemia linfoblástica aguda de precursores B

dc.contributor.advisorGuerrero Fonseca, Carlos Arturospa
dc.contributor.advisorAcosta Losada, Orlandospa
dc.contributor.authorGuerrero Rojas, Rafael Antoniospa
dc.contributor.corporatenameLaboratorio de Biología Molecular de Virus - Facultad de Medicina - Universidad Nacional de Colombiaspa
dc.contributor.researchgroupBiología Molecular de virusspa
dc.date.accessioned2020-09-04T17:00:01Zspa
dc.date.available2020-09-04T17:00:01Zspa
dc.date.issued2018-09-28spa
dc.description.abstractCancer is a major health problem that poses a great challenge to health care systems around the world. Current tools for cancer treatment have advanced rapidly in recent years, resulting in new alternative and complementary therapeutic strategies to conventional treatment. Work aims to identify the oncolytic potential of rotavirus Wt1-5 adapted to tumor cells, in addition, to establish the cell surface receptors and markers of cell death induced by rotavirus infection in B- cell acute lymphoblastic leukemia cells and Reh cells. We used Wt1 -5 rotavirus isolate recently adapted to tumor cells, to infect the B- cell acute lymphoblastic leukemia cells and Reh cells. We assessed rotavirus infection by viral antigens detection through flow cytometry analysis. Also, we analyze some cell surface proteins and cell death markers induced by viral infection. The assays showed that rotavirus Wt1 -5 was able to use cell-surface proteins such as heat shock proteins Hsp90, Hsp70, Hsc70, PDI, and β3 integrin. Rotavirus Wt1-5 induced cytotoxic effects including changes in cell membrane permeability, alteration of mitochondrial membrane potential, DNA fragmentation, and activation of cell death signaling. We conclude that rotavirus Wt1 -5 may be a potential candidate to be used as an oncolytic agent. This rotavirus could induce apoptosis as a cell death mechanism in B- cell acute lymphoblastic leukemia cells and Reh cells.spa
dc.description.abstractEl cáncer es un importante problema de salud que plantea un gran desafío para los sistemas de atención de salud en todo el mundo. Las herramientas para el tratamiento del cáncer han avanzado rápidamente en los últimos años, dando como resultado nuevas estrategias terapéuticas alternativas y complementarias al tratamiento convencional. Este trabajo busca identificar el potencial oncolítico del rotavirus Wt1-5 adaptado a células tumorales y algunos de los receptores de superficie celular utilizados por el rotavirus Wt1-5 y los marcadores de muerte celular inducidos por la infección en células de leucemia linfoblástica aguda de precursores B y células Reh. Para esto, se usó el aislamiento de rotavirus Wt -5 recientemente adaptado a células tumorales, para infectar las células de leucemia linfoblástica aguda de precursores B y las células Reh. La infección por rotavirus Wt1 -5 fue seguida mediante análisis de antígenos virales por citometría de flujo. Se evaluaron algunas proteínas de superficie celular como posibles receptores y marcadores de muerte celular inducidos por la infección viral. El trabajo muestra que el rotavirus Wt1-5 fue capaz de utilizar las proteínas de la superficie celular como las proteínas de choque térmico Hsp90, Hsp70, Hsc70, PDI e integrina β3. El rotavirus Wt1-5 indujo efectos citotóxicos que incluyen cambios en la permeabilidad de la membrana celular, alteración del potencial de membrana mitocondrial, fragmentación del ADN y activación de la señalización de la muerte celular. Concluimos que el rotavirus Wt1 -5 puede ser un candidato potencial para ser utilizado como un agente oncolítico y que la apoptosis podría ser un mecanismo por el cual Wt1-5 reducir la viabilidad de las células de leucemia linfoblástica aguda de precursores y las células Reh.spa
dc.description.additionalLínea de Investigación: Virus Oncolíticosspa
dc.description.degreelevelDoctoradospa
dc.description.projectEvaluación in vitro de virus oncolítico para el tratamiento de leucemia linfoblástica aguda en muestras de sangre periférica de pacientes en edad pediátrica.spa
dc.description.sponsorshipDepartamento Administrativo de Ciencia, Tecnología e Innovación, COLCIENCIAS, Convocatoria No. 110171250829.spa
dc.format.extent216spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.citationRafael A. Guerrero, Carlos A. Guerrero, Orlando Acosta. (2018) Caracterización del potencial oncolítico del aislamiento rotaviral Wt1 -5 en cultivos primarios de leucemia linfoblástica aguda de precursores B. Doctorado en Biotecnología, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá-Colombiaspa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/78384
dc.language.isospaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.programBogotá - Ciencias - Doctorado en Biotecnologíaspa
dc.relation.referencesSiegel, R. L., Miller, K. D., and Jemal, A. (2017) Cancer Statistics, 2017, CA Cancer J Clin 67, 7-30.spa
dc.relation.referencesJabbour, E., O'Brien, S., Konopleva, M., and Kantarjian, H. (2015) New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia, Cancer 121, 2517-2528.spa
dc.relation.referencesHunger, S. P., and Mullighan, C. G. (2015) Acute Lymphoblastic Leukemia in Children, N Engl J Med 373, 1541-1552.spa
dc.relation.referencesTerwilliger, T., and Abdul-Hay, M. (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update, Blood Cancer J 7, e577.spa
dc.relation.referencesGupta, S., Antillon, F. A., Bonilla, M., Fu, L., Howard, S. C., Ribeiro, R. C., and Sung, L. (2011) Treatment-related mortality in children with acute lymphoblastic leukemia in Central America, Cancer 117, 4788-4795.spa
dc.relation.referencesKato, M., and Manabe, A. (2017) Treatment and biology of pediatric acute lymphoblastic leukemia, Pediatr Int 60, 4-12.spa
dc.relation.referencesNess, K. K., Armenian, S. H., Kadan-Lottick, N., and Gurney, J. G. (2011) Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health, Expert Rev Hematol 4, 185-197.spa
dc.relation.referencesShah, N., Al-Ahmari, A., Al-Yamani, A., Dupuis, L., Stephens, D., and Hitzler, J. (2009) Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome, Pediatr Blood Cancer 52, 14-19.spa
dc.relation.referencesGarzon, R., Calin, G. A., and Croce, C. M. (2009) MicroRNAs in Cancer, Annu Rev Med 60, 167-179.spa
dc.relation.referencesGarzon, R., Marcucci, G., and Croce, C. M. (2010) Targeting microRNAs in cancer: rationale, strategies and challenges, Nat Rev Drug Discov 9, 775-789.spa
dc.relation.referencesGuo, W., Chen, W., Yu, W., Huang, W., and Deng, W. (2013) Small interfering RNA-based molecular therapy of cancers, Chin J Cancer 32, 488-493.spa
dc.relation.referencesde Fougerolles, A., Vornlocher, H. P., Maraganore, J., and Lieberman, J. (2007) Interfering with disease: a progress report on siRNA-based therapeutics, Nat Rev Drug Discov 6, 443-453.spa
dc.relation.referencesNakamura, K., and Smyth, M. J. (2017) Targeting cancer-related inflammation in the era of immunotherapy, Immunol Cell Biol 95, 325-332.spa
dc.relation.referencesBagnyukova, T. V., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., and Astsaturov, I. (2010) Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?, Cancer Biol Ther 10, 839-853.spa
dc.relation.referencesAtherton, M. J., and Lichty, B. D. (2013) Evolution of oncolytic viruses: novel strategies for cancer treatment, Immunotherapy 5, 1191-1206.spa
dc.relation.referencesPatel, M. R., and Kratzke, R. A. (2013) Oncolytic virus therapy for cancer: the first wave of translational clinical trials, Transl Res 161, 355-364.spa
dc.relation.referencesLiu, T. C., and Kirn, D. (2007) Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions, Cancer Res 67, 429-432.spa
dc.relation.referencesRoberts, M. S., Lorence, R. M., Groene, W. S., and Bamat, M. K. (2006) Naturally oncolytic viruses, Curr Opin Mol Ther 8, 314-321.spa
dc.relation.referencesGarant, K. A., Shmulevitz, M., Pan, L., Daigle, R. M., Ahn, D. G., Gujar, S. A., and Lee, P. W. (2016) Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release, Oncogene 35, 771-782.spa
dc.relation.referencesGuo, Z. S., Thorne, S. H., and Bartlett, D. L. (2008) Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses, Biochim Biophys Acta 1785, 217-231.spa
dc.relation.referencesVaha-Koskela, M., and Hinkkanen, A. (2014) Tumor Restrictions to Oncolytic Virus, Biomedicines 2, 163-194.spa
dc.relation.referencesGuerrero, C. A., Mendez, E., Zarate, S., Isa, P., Lopez, S., and Arias, C. F. (2000) Integrin alpha(v)beta(3) mediates rotavirus cell entry, Proc Natl Acad Sci U S A 97, 14644-14649.spa
dc.relation.referencesZarate, S., Romero, P., Espinosa, R., Arias, C. F., and Lopez, S. (2004) VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site, J Virol 78, 10839-10847.spa
dc.relation.referencesZarate, S., Espinosa, R., Romero, P., Guerrero, C. A., Arias, C. F., and Lopez, S. (2000) Integrin alpha2beta1 mediates the cell attachment of the rotavirus neuraminidase-resistant variant nar3, Virology 278, 50-54.spa
dc.relation.referencesCiarlet, M., Crawford, S. E., Cheng, E., Blutt, S. E., Rice, D. A., Bergelson, J. M., and Estes, M. K. (2002) VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment, J Virol 76, 1109-1123.spa
dc.relation.referencesHewish, M. J., Takada, Y., and Coulson, B. S. (2000) Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells, J Virol 74, 228-236.spa
dc.relation.referencesLondrigan, S. L., Hewish, M. J., Thomson, M. J., Sanders, G. M., Mustafa, H., and Coulson, B. S. (2000) Growth of rotaviruses in continuous human and monkey cell lines that vary in their expression of integrins, J Gen Virol 81, 2203-2213.spa
dc.relation.referencesGualtero, D. F., Guzman, F., Acosta, O., and Guerrero, C. A. (2007) Amino acid domains 280-297 of VP6 and 531-554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection, Arch Virol 152, 2183-2196.spa
dc.relation.referencesGuerrero, C. A., Bouyssounade, D., Zarate, S., Isa, P., Lopez, T., Espinosa, R., Romero, P., Mendez, E., Lopez, S., and Arias, C. F. (2002) Heat shock cognate protein 70 is involved in rotavirus cell entry, J Virol 76, 4096-4102.spa
dc.relation.referencesZarate, S., Cuadras, M. A., Espinosa, R., Romero, P., Juarez, K. O., Camacho-Nuez, M., Arias, C. F., and Lopez, S. (2003) Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5, J Virol 77, 7254-7260.spa
dc.relation.referencesZarate, S., Cuadras, M. A., Espinosa, R., Romero, P., Juarez, K. O., Camacho-Nuez, M., Arias, C. F., and Lopez, S. (2003) Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5, J Virol 77, 7254-7260.spa
dc.relation.referencesCalderon, M. N., Guerrero, C. A., Dominguez, Y., Garzon, E., Barreto, S. M., and Acosta, O. (2011) [Interaction of rotavirus with protein disulfide isomerase in vitro and cell system], Biomedica 31, 70-81.spa
dc.relation.referencesCalderón, M. G., F. Acosta, O. Guerrero, C. (2012) Rotavirus VP4 and VP7-Derived Synthetic Peptides as Potential Substrates of Protein Disulfide Isomerase Lead to Inhibition of Rotavirus Infection., International Journal of Peptide Research and Therapeutics. 18., 373–382.spa
dc.relation.referencesDesgrosellier, J. S., and Cheresh, D. A. (2010) Integrins in cancer: biological implications and therapeutic opportunities, Nat Rev Cancer 10, 9-22.spa
dc.relation.referencesWu, J., Liu, T., Rios, Z., Mei, Q., Lin, X., and Cao, S. (2017) Heat Shock Proteins and Cancer, Trends Pharmacol Sci 38, 226-256.spa
dc.relation.referencesLee, E., and Lee, D. H. (2017) Emerging roles of protein disulfide isomerase in cancer, BMB Rep 50, 401-410.spa
dc.relation.referencesGuerrero, C. A., Guerrero, R. A., Silva, E., Acosta, O., and Barreto, E. (2016) Experimental Adaptation of Rotaviruses to Tumor Cell Lines, PLoS One 11, e0147666.spa
dc.relation.referencesKoonin, E. V., Senkevich, T. G., and Dolja, V. V. (2006) The ancient Virus World and evolution of cells, Biol Direct 1, 29.spa
dc.relation.referencesChiocca, E. A. (2002) Oncolytic viruses, Nat Rev Cancer 2, 938-950.spa
dc.relation.referencesMartuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., and Coen, D. M. (1991) Experimental therapy of human glioma by means of a genetically engineered virus mutant, Science 252, 854-856.spa
dc.relation.referencesMarkert, J. M., Malick, A., Coen, D. M., and Martuza, R. L. (1993) Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir, Neurosurgery 32, 597-603.spa
dc.relation.referencesFountzilas, C., Patel, S., & Mahalingam, D. (2017). Oncolytic virotherapy, updates and future directions. Oncotarget, 8(60).spa
dc.relation.referencesAsada, T. (1974) Treatment of human cancer with mumps virus, Cancer 34, 1907-1928.spa
dc.relation.referencesWheelock, E. F., and Dingle, J. H. (1964) Observations on the Repeated Administration of Viruses to a Patient with Acute Leukemia. A Preliminary Report, N Engl J Med 271, 645-651.spa
dc.relation.referencesBluming, A. Z., and Ziegler, J. L. (1971) Regression of Burkitt's lymphoma in association with measles infection, Lancet 2, 105-106.spa
dc.relation.referencesTaqi, A. M., Abdurrahman, M. B., Yakubu, A. M., and Fleming, A. F. (1981) Regression of Hodgkin's disease after measles, Lancet 1, 1112.spa
dc.relation.referencesMoore, A. E. (1952) Viruses with oncolytic properties and their adaptation to tumors, Ann N Y Acad Sci 54, 945-952.spa
dc.relation.referencesMoore, A. E. (1954) Effects of viruses on tumors, Annu Rev Microbiol 8, 393-410.spa
dc.relation.referencesNewman, W., and Southam, C. M. (1954) Virus treatment in advanced cancer; a pathological study of fifty-seven cases, Cancer 7, 106-118.spa
dc.relation.referencesCassel, W. A., and Garrett, R. E. (1965) Newcastle Disease Virus as an Antineoplastic Agent, Cancer 18, 863-868.spa
dc.relation.referencesVaha-Koskela, M. J., Heikkila, J. E., and Hinkkanen, A. E. (2007) Oncolytic viruses in cancer therapy, Cancer Lett 254, 178-216.spa
dc.relation.referencesSoutham, C. M. (1960) Present status of oncolytic virus studies, Trans N Y Acad Sci 22, 657-673.spa
dc.relation.referencesGanly, I., Kirn, D., Eckhardt, G., Rodriguez, G. I., Soutar, D. S., Otto, R., Robertson, A. G., Park, O., Gulley, M. L., Heise, C., Von Hoff, D. D., and Kaye, S. B. (2000) A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer, Clin Cancer Res 6, 798-806.spa
dc.relation.referencesGanly, I., Mautner, V., and Balmain, A. (2000) Productive replication of human adenoviruses in mouse epidermal cells, J Virol 74, 2895-2899.spa
dc.relation.referencesAghi, M., and Martuza, R. L. (2005) Oncolytic viral therapies - the clinical experience, Oncogene 24, 7802-7816.spa
dc.relation.referencesTyler, K. L., Squier, M. K., Brown, A. L., Pike, B., Willis, D., Oberhaus, S. M., Dermody, T. S., and Cohen, J. J. (1996) Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes, J Virol 70, 7984-7991.spa
dc.relation.referencesSabin, A. B. (1959) Reoviruses. A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described, Science 130, 1387-1389.spa
dc.relation.referencesHashiro, G., Loh, P. C., and Yau, J. T. (1977) The preferential cytotoxicity of reovirus for certain transformed cell lines, Arch Virol 54, 307-315.spa
dc.relation.referencesDuncan, M. R., Stanish, S. M., and Cox, D. C. (1978) Differential sensitivity of normal and transformed human cells to reovirus infection, J Virol 28, 444-449.spa
dc.relation.referencesStoeckel, J., and Hay, J. G. (2006) Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic, Curr Opin Mol Ther 8, 249-260.spa
dc.relation.referencesMorris, D. G., Forsyth, PA, Paterson, AH, Fonseca, K, Difrancesco, L.M, Thompson, BG et al. . (2002) A phase I clinical trial evaluating intralesional Reolysin (reovirus) in histologically confirmed malignancies., ASCO Annual Meeting 54. 244-256.spa
dc.relation.referencesForsyth, P., Roldan, G., George, D., Wallace, C., Palmer, C. A., Morris, D., Cairncross, G., Matthews, M. V., Markert, J., Gillespie, Y., Coffey, M., Thompson, B., and Hamilton, M. (2008) A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas, Mol Ther 16, 627-632.spa
dc.relation.referencesStrong, J. E., Coffey, M. C., Tang, D., Sabinin, P., and Lee, P. W. (1998) The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus, EMBO J 17, 3351-3362.spa
dc.relation.referencesCoffey, M. C., Strong, J. E., Forsyth, P. A., and Lee, P. W. (1998) Reovirus therapy of tumors with activated Ras pathway, Science 282, 1332-1334.spa
dc.relation.referencesNorman, K. L., Hirasawa, K., Yang, A. D., Shields, M. A., and Lee, P. W. (2004) Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection, Proc Natl Acad Sci U S A 101, 11099-11104.spa
dc.relation.referencesThirukkumaran, C. M., Luider, J. M., Stewart, D. A., Cheng, T., Lupichuk, S. M., Nodwell, M. J., Russell, J. A., Auer, I. A., and Morris, D. G. (2003) Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation, Blood 102, 377-387.spa
dc.relation.referencesSmakman, N., van den Wollenberg, D. J., Borel Rinkes, I. H., Hoeben, R. C., and Kranenburg, O. (2005) Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D, J Virol 79, 14981-14985.spa
dc.relation.referencesKim, M., Egan, C., Alain, T., Urbanski, S. J., Lee, P. W., Forsyth, P. A., and Johnston, R. N. (2007) Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells, Oncogene 26, 4124-4134.spa
dc.relation.referencesComins, C., Heinemann, L., Harrington, K., Melcher, A., De Bono, J., and Pandha, H. (2008) Reovirus: viral therapy for cancer 'as nature intended', Clin Oncol (R Coll Radiol) 20, 548-554.spa
dc.relation.referencesEuropean, M. A. (2008) The international conference on harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use. ICH considetarions to oncolytic visuses, EMEA EMEA/CHMP/ICH/607698/2008, 1-6.spa
dc.relation.referencesEstes, M. K., and Cohen, J. (1989) Rotavirus gene structure and function, Microbiol Rev 53, 410-449.spa
dc.relation.referencesEstes, M. K., and Graham, D. Y. (1985) Rotavirus antigens, Adv Exp Med Biol 185, 201-214.spa
dc.relation.referencesKalica A. R., F. J., Greenberg B. H (1983) Identification of the Rotaviral Gene that Codes for Hemagglutination and Protease-enhanced Plaque Formation, Virology 125, 194 – 20spa
dc.relation.referencesPesavento, J. B., Crawford, S. E., Roberts, E., Estes, M. K., and Prasad, B. V. (2005) pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization, J Virol 79, 8572-8580.spa
dc.relation.referencesArias, C. F., Dector, M. A., Segovia, L., Lopez, T., Camacho, M., Isa, P., Espinosa, R., and Lopez, S. (2004) RNA silencing of rotavirus gene expression, Virus Res 102, 43-51.spa
dc.relation.referencesBagchi, P., Dutta, D., Chattopadhyay, S., Mukherjee, A., Halder, U. C., Sarkar, S., Kobayashi, N., Komoto, S., Taniguchi, K., and Chawla-Sarkar, M. (2010) Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection, J Virol 84, 6834-6845.spa
dc.relation.referencesLopez, S., and Arias, C. F. (2006) Early steps in rotavirus cell entry, Curr Top Microbiol Immunol 309, 39-66.spa
dc.relation.referencesBlutt, S. E., and Conner, M. E. (2007) Rotavirus: to the gut and beyond!, Curr Opin Gastroenterol 23, 39-43.spa
dc.relation.referencesBerkova, Z., Crawford, S. E., Blutt, S. E., Morris, A. P., and Estes, M. K. (2007) Expression of rotavirus NSP4 alters the actin network organization through the actin remodeling protein cofilin, J Virol 81, 3545-3553.spa
dc.relation.referencesBanyai, K., Mijatovic-Rustempasic, S., Hull, J. J., Esona, M. D., Freeman, M. M., Frace, A. M., Bowen, M. D., and Gentsch, J. R. (2011) Sequencing and phylogenetic analysis of the coding region of six common rotavirus strains: evidence for intragenogroup reassortment among co-circulating G1P[8] and G2P[4] strains from the United States, J Med Virol 83, 532-539.spa
dc.relation.referencesOrganization, P. A. H. (2007) Epidemiologic surveillance of diarrheal diseases due to rotavirus: Field guide, Organización Panamericana de la Salud Publicación Científica y Técnica No. 623, 12-43.spa
dc.relation.referencesParashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A., and Glass, R. I. (2003) Global illness and deaths caused by rotavirus disease in children, Emerg Infect Dis 9, 565-572.spa
dc.relation.referencesBern, C., Martines, J., de Zoysa, I., and Glass, R. I. (1992) The magnitude of the global problem of diarrhoeal disease: a ten-year update, Bull World Health Organ 70, 705-714.spa
dc.relation.referencesLeung, A. K., Kellner, J. D., and Davies, H. D. (2005) Rotavirus gastroenteritis, Adv Ther 22, 476-487.spa
dc.relation.referencesLópez, P., Cáceres, D., López, E. (2005) Enfermedad por rotavirus, características epidemiológicas, características epidemiológicas,clínicas, prevención y manejo, CCAP 6, 2.45, 45-55.spa
dc.relation.referencesArias, C. F., Isa, P., Guerrero, C. A., Mendez, E., Zarate, S., Lopez, T., Espinosa, R., Romero, P., and Lopez, S. (2002) Molecular biology of rotavirus cell entry, Arch Med Res 33, 356-361.spa
dc.relation.referencesRamig, R. F. (2004) Pathogenesis of intestinal and systemic rotavirus infection, J Virol 78, 10213-10220.spa
dc.relation.referencesBlutt, S. E., Matson, D. O., Crawford, S. E., Staat, M. A., Azimi, P., Bennett, B. L., Piedra, P. A., and Conner, M. E. (2007) Rotavirus antigenemia in children is associated with viremia, PLoS Med 4, e121.spa
dc.relation.referencesFeng, N., Kim, B., Fenaux, M., Nguyen, H., Vo, P., Omary, M. B., and Greenberg, H. B. (2008) Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice, J Virol 82, 7578-7590.spa
dc.relation.referencesCiarlet, M., Ludert, J. E., Iturriza-Gomara, M., Liprandi, F., Gray, J. J., Desselberger, U., and Estes, M. K. (2002) Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin, J Virol 76, 4087-4095.spa
dc.relation.referencesCiarlet, M., Hyser, J. M., and Estes, M. K. (2002) Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3, Virus Genes 24, 107-118.spa
dc.relation.referencesSantana, A. Y., Guerrero, C. A., and Acosta, O. (2013) Implication of Hsc70, PDI and integrin alphavbeta3 involvement during entry of the murine rotavirus ECwt into small-intestinal villi of suckling mice, Arch Virol 158, 1323-1336.spa
dc.relation.referencesIsa, P., Arias, C. F., and Lopez, S. (2006) Role of sialic acids in rotavirus infection, Glycoconj J 23, 27-37.spa
dc.relation.referencesCiarlet, M., Crawford, S. E., and Estes, M. K. (2001) Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains, J Virol 75, 11834-11850.spa
dc.relation.referencesFleming, F. E., Graham, K. L., Taniguchi, K., Takada, Y., and Coulson, B. S. (2007) Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1, Arch Virol 152, 1087-1101.spa
dc.relation.referencesGraham, K. L., Fleming, F. E., Halasz, P., Hewish, M. J., Nagesha, H. S., Holmes, I. H., Takada, Y., and Coulson, B. S. (2005) Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands, J Gen Virol 86, 3397-3408.spa
dc.relation.referencesGraham, K. L., Zeng, W., Takada, Y., Jackson, D. C., and Coulson, B. S. (2004) Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences, J Virol 78, 11786-11797.spa
dc.relation.referencesGraham, K. L., Halasz, P., Tan, Y., Hewish, M. J., Takada, Y., Mackow, E. R., Robinson, M. K., and Coulson, B. S. (2003) Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry, J Virol 77, 9969-9978.spa
dc.relation.referencesGuerrero, C. A., and Moreno, L. P. (2012) Rotavirus receptor proteins Hsc70 and integrin alphavbeta3 are located in the lipid microdomains of animal intestinal cells, Acta Virol 56, 63-70.spa
dc.relation.referencesCalderón, M., Guzmán, Fanny., Acosta, Orlando., Guerrero, Carlos. (2012) Rotavirus VP4 and VP7-derived synthetic peptides as potential substrates of protein disulfide isomerase lead to inhibition of rotavirus infection, International Journal of Peptide Research and Therapeutics.spa
dc.relation.referencesGuerrero, C. A., Murillo, A., and Acosta, O. (2012) Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARgamma agonists and NSAIDs, Antiviral Res 96, 1-12.spa
dc.relation.referencesGuerrero, C. A., Murillo, A., and Acosta, O. (2012) Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARgamma agonists and NSAIDs, Antiviral Res 96, 1-12.spa
dc.relation.referencesLloyd-Evans, N., Springthorpe, V. S., and Sattar, S. A. (1986) Chemical disinfection of human rotavirus-contaminated inanimate surfaces, J Hyg (Lond) 97, 163-173.spa
dc.relation.referencesWard, R. L., Bernstein, D. I., Knowlton, D. R., Sherwood, J. R., Young, E. C., Cusack, T. M., Rubino, J. R., and Schiff, G. M. (1991) Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray, J Clin Microbiol 29, 1991-1996.spa
dc.relation.referencesWeiss, C., and Clark, H. F. (1985) Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice, J Gen Virol 66 ( Pt 12), 2725-2730.spa
dc.relation.referencesEstes, M. K., Graham, D. Y., Smith, E. M., and Gerba, C. P. (1979) Rotavirus stability and inactivation, J Gen Virol 43, 403-409.spa
dc.relation.referencesFischer, T. K., Valentiner-Branth, P., Steinsland, H., Perch, M., Santos, G., Aaby, P., Molbak, K., and Sommerfelt, H. (2002) Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa, J Infect Dis 186, 593-597.spa
dc.relation.referencesRodrigues, A., de Carvalho, M., Monteiro, S., Mikkelsen, C. S., Aaby, P., Molbak, K., and Fischer, T. K. (2007) Hospital surveillance of rotavirus infection and nosocomial transmission of rotavirus disease among children in Guinea-Bissau, Pediatr Infect Dis J 26, 233-237.spa
dc.relation.referencesMartella, V., Banyai, K., Matthijnssens, J., Buonavoglia, C., and Ciarlet, M. (2010) Zoonotic aspects of rotaviruses, Vet Microbiol 140, 246-255.spa
dc.relation.referencesCDC, C. f. d. c. a. p. (2009) Biosafety in microbiologycal and biomedical laboratories. 5 th edition., U.S. Departament of health an human services 21-1112.spa
dc.relation.referencesWHO, W. H. O. (2005) Laboratory biosafety manual., World Health Organization 3th Edition.spa
dc.relation.referencesRitossa, F. (1962) A new puffing pattern induced by temperature shock and DNP in Drosophila, Experientia 18, 571–573.spa
dc.relation.referencesMorimoto, R. I. (1998) Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators, Genes Dev 12, 3788-3796.spa
dc.relation.referencesWhitley, D., Goldberg, S. P., and Jordan, W. D. (1999) Heat shock proteins: a review of the molecular chaperones, J Vasc Surg 29, 748-751.spa
dc.relation.referencesCoronato, S., Di Girolamo, W., Salas, Margatira., Spinelli, O., Languens, G. (1999) Biología de las proteínas del shock térmico, Journal de Medicina Buenos Aires 59, 477-486.spa
dc.relation.referencesPoulain, P., Gelly, J. C., and Flatters, D. (2010) Detection and architecture of small heat shock protein monomers, PLoS One 5, e9990.spa
dc.relation.referencesHu Z, C. L., Zhang J, Li T, Tang J, Xu N, Wang X. (2007) Structure, function, property, and role in neurologic diseases and other diseases of the sHsp22, J Neurosci Res 85, 2071-2079.spa
dc.relation.referencesIrobi, J., Van Impe, K., Seeman, P., Jordanova,A., Dierick, I., et al (2004) Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy, Nature 36, 597-601.spa
dc.relation.referencesAckerley, S., James, P., Kalli, A., French, S., Davies, K., Talbot, K. (2006) A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes, Hum Mol Genet 15, 347-354.spa
dc.relation.referencesVan de Klundert, F., Gijsen, M., Van del ljssel, P., Snoeckx, L. (1998) Alpha B-crystallin and hsp25 in neonatal cardiac cells differences in cellular localization under stress conditions. Eur J Cell Biol Eur J Cell Biol 75, 38-45.spa
dc.relation.referencesKlemenz, R., Andres, A., Fröhli, E., Schäfer, R., Aoyama, A. (1993) Expression of the murine small heat shock proteins hsp25 and α B crystallin in the absence of stress, J Cell Biol 120, 639-645.spa
dc.relation.referencesHoulden, H., De Vrièze, W., Blake, J., Wood, N., Reilly, M. (2008) Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2, Neurology 71, 1660-1668.spa
dc.relation.referencesCiocca, D., Stati, A., Fanelli, M., Gaestel, M. (1996) Expression of heat shock protein 25000 in rat uterus during pregnancy and pseudopregnancy Biol Reprod 54, 1326-1335.spa
dc.relation.referencesLi, D., Gordon, C., Stagg, C., Udelsman, R. . (1996) Heat shock protein expression in human placenta and umbilical cord, Shock 5, 320-323.spa
dc.relation.referencesXu, Q., and Wick, G. (1996) The role of heat shock proteins in protection and pathophysiology of the arterial wall, Mol Med Today 2, 372-379.spa
dc.relation.referencesHassan, S., Biswas, M. H., Zhang, C., Du, C., and Balaji, K. C. (2009) Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells, Oncogene 28, 4386-4396.spa
dc.relation.referencesCiocca, D. R., and Luque, E. H. (1991) Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer, Breast Cancer Res Treat 20, 33-42.spa
dc.relation.referencesDavey, K., Parboosingh, J., McLeod, D., Chan. A., Casey, R., Ferreira, P., Snyder, F., Bridge, P., Bernier, F. (2006) Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition, J Med Genet 43, 385-393.spa
dc.relation.referencesHata, M., Okumura, K., Seto, M., and Ohtsuka, K. (1996) Genomic cloning of a human heat shock protein 40 (Hsp40) gene (HSPF1) and its chromosomal localization to 19p13.2, Genomics 38, 446-449.spa
dc.relation.referencesBorges, J. C., Fischer, H., Craievich, A. F., and Ramos, C. H. (2005) Low resolution structural study of two human HSP40 chaperones in solution. DJA1 from subfamily A and DJB4 from subfamily B have different quaternary structures, The Journal of biological chemistry 280, 13671-13681.spa
dc.relation.referencesHansen, J. J., Bross, P., Westergaard, M., Nielsen, M. N., Eiberg, H., Borglum, A. D., Mogensen, J., Kristiansen, K., Bolund, L., and Gregersen, N. (2003) Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter, Hum Genet 112, 71-77.spa
dc.relation.referencesBukau, B., and Horwich, A. L. (1998) The Hsp70 and Hsp60 chaperone machines, Cell 92, 351-366.spa
dc.relation.referencesHendershot, L. M., Valentine, V. A., Lee, A. S., Morris, S. W., and Shapiro, D. N. (1994) Localization of the gene encoding human BiP/GRP78, the endoplasmic reticulum cognate of the HSP70 family, to chromosome 9q34, Genomics 20, 281-284.spa
dc.relation.referencesBrocchieri, L., Conway de Macario, E., Macario, A. . (2008) hsp70 genes in the human genome: Conservation and differentiation patterns predict a wide array of overlapping and specialized functions, BMC Evol Biol 23, 8-19.spa
dc.relation.referencesOsipiuk, J., Walsh, M. A., Freeman, B. C., Morimoto, R. I., and Joachimiak, A. (1999) Structure of a new crystal form of human Hsp70 ATPase domain, Acta Crystallogr D Biol Crystallogr 55, 1105-1107.spa
dc.relation.referencesChen, B., Piel, W. H., Gui, L., Bruford, E., and Monteiro, A. (2005) The HSP90 family of genes in the human genome: insights into their divergence and evolution, Genomics 86, 627-637.spa
dc.relation.referencesSidera, K., Samiotaki, M., Yfanti, E., Panayotou, G., and Patsavoudi, E. (2004) Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system, The Journal of biological chemistry 279, 45379-45388.spa
dc.relation.referencesBecker, B., Multhoff, G., Farkas, B., Wild, P. J., Landthaler, M., Stolz, W., and Vogt, T. (2004) Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases, Exp Dermatol 13, 27-32.spa
dc.relation.referencesTsutsumi, S., and Neckers, L. (2007) Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis, Cancer Sci 98, 1536-1539.spa
dc.relation.referencesHelmbrecht, K., Zeise, E., and Rensing, L. (2000) Chaperones in cell cycle regulation and mitogenic signal transduction: a review, Cell Prolif 33, 341-365.spa
dc.relation.referencesDidelot, C., Schmitt, E., Brunet, M., Maingret, L., Parcellier, A., and Garrido, C. (2006) Heat shock proteins: endogenous modulators of apoptotic cell death, Handb Exp Pharmacol, 171-198.spa
dc.relation.referencesLi, Z. (2001) The roles of heat shock proteins in tumor immunity, Cancer Chemother Biol Response Modif 19, 371-383.spa
dc.relation.referencesMulthoff, G. (2006) Heat shock proteins in immunity, Handb Exp Pharmacol, 279-304.spa
dc.relation.referencesCalderwood, S. K., Khaleque, M. A., Sawyer, D. B., and Ciocca, D. R. (2006) Heat shock proteins in cancer: chaperones of tumorigenesis, Trends Biochem Sci 31, 164-172.spa
dc.relation.referencesShin, B. K., Wang, H., Yim, A. M., Le Naour, F., Brichory, F., Jang, J. H., Zhao, R., Puravs, E., Tra, J., Michael, C. W., Misek, D. E., and Hanash, S. M. (2003) Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function, J Biol Chem 278, 7607-7616.spa
dc.relation.referencesArrigo, A. P. (2005) [Heat shock proteins as molecular chaperones], Med Sci (Paris) 21, 619-625.spa
dc.relation.referencesSpiess, C., Meyer, A. S., Reissmann, S., and Frydman, J. (2004) Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets, Trends Cell Biol 14, 598-604.spa
dc.relation.referencesYoung, J. C., Agashe, V. R., Siegers, K., and Hartl, F. U. (2004) Pathways of chaperone-mediated protein folding in the cytosol, Nat Rev Mol Cell Biol 5, 781-791.spa
dc.relation.referencesMayer, M. P., and Bukau, B. (2005) Hsp70 chaperones: cellular functions and molecular mechanism, Cell Mol Life Sci 62, 670-684.spa
dc.relation.referencesWegele, H., Muller, L., and Buchner, J. (2004) Hsp70 and Hsp90--a relay team for protein folding, Rev Physiol Biochem Pharmacol 151, 1-44.spa
dc.relation.referencesPratt, W. B., and Toft, D. O. (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery, Exp Biol Med (Maywood) 228, 111-133.spa
dc.relation.referencesEaston, D. P., Kaneko, Y., and Subjeck, J. R. (2000) The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s, Cell stress & chaperones 5, 276-290.spa
dc.relation.referencesCiocca, D. R., and Calderwood, S. K. (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications, Cell Stress Chaperones 10, 86-103.spa
dc.relation.referencesXu, A., Tian, Tian., Hao, Jia., Liu, Jifu., Zhang, Zhao. (2007) Elevation of Serum HSP90α Correlated with the Clinical stage of Non-Small Cell Lung Cancer, Journal of Cancer Molecules 3 (4), 107-112.spa
dc.relation.referencesSzymanska, Z., Urbanski, J., and Marciniak-Czochra, A. (2009) Mathematical modelling of the influence of heat shock proteins on cancer invasion of tissue, J Math Biol 58, 819-844.spa
dc.relation.referencesGlaessgen, A., Jonmarker, S., Lindberg, A., Nilsson, B., Lewensohn, R., Ekman, P., Valdman, A., and Egevad, L. (2008) Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer, APMIS 116, 888-895.spa
dc.relation.referencesGarg, M., Kanojia, D., Seth, A., Kumar, R., Gupta, A., Surolia, A., and Suri, A. (2010) Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion, Eur J Cancer 46, 207-215.spa
dc.relation.referencesReyes-Del Valle, J., Chavez-Salinas, S., Medina, F., and Del Angel, R. M. (2005) Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells, J Virol 79, 4557-4567.spa
dc.relation.referencesLi, G., Zhang, J., Tong, X., Liu, W., and Ye, X. (2011) Heat shock protein 70 inhibits the activity of Influenza A virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo, PLoS One 6, e16546.spa
dc.relation.referencesGonzalez, O., Fontanes, V., Raychaudhuri, S., Loo, R., Loo, J., Arumugaswami, V., Sun, R., Dasgupta, A., and French, S. W. (2009) The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production, Hepatology 50, 1756-1764.spa
dc.relation.referencesHu, J., Flores, D., Toft, D., Wang, X., and Nguyen, D. (2004) Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function, J Virol 78, 13122-13131.spa
dc.relation.referencesKumar, M., and Mitra, D. (2005) Heat shock protein 40 is necessary for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication, J Biol Chem 280, 40041-40050.spa
dc.relation.referencesLaFlamme, S. E., and Auer, K. L. (1996) Integrin signaling, Semin Cancer Biol 7, 111-118.spa
dc.relation.referencesFilippo, G., Ruoslaht, Erkki. (1999) Integrin Signaling, Science 285 (5430), 1028-1033.spa
dc.relation.referencesJiménez, Á., . Garrido J., Barbancho, Manuel. (2003) Caracterización molecular de las integrinas beta-1 (CD29) y beta-3 (CD61) porcinas. Obtención de anticuerpos contra dominios específicos de ambas moléculas, Universidad de Córdoba, Servicio de Publicaciones.spa
dc.relation.referencesClezardin, P. (1998) Recent insights into the role of integrins in cancer metastasis, Cell Mol Life Sci 54, 541-548.spa
dc.relation.referencesParry, C., Bell, S., Minson, T., and Browne, H. (2005) Herpes simplex virus type 1 glycoprotein H binds to alphavbeta3 integrins, J Gen Virol 86, 7-10.spa
dc.relation.referencesWickham, T. J., Mathias, P., Cheresh, D. A., and Nemerow, G. R. (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment, Cell 73, 309-319.spa
dc.relation.referencesTriantafilou, K., Triantafilou, M., Takada, Y., and Fernandez, N. (2000) Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors, J Virol 74, 5856-5862.spa
dc.relation.referencesXiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., and Arnaout, M. A. (2002) Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand, Science 296, 151-155.spa
dc.relation.referencesStromblad, S., and Cheresh, D. A. (1996) Integrins, angiogenesis and vascular cell survival, Chem Biol 3, 881-885.spa
dc.relation.referencesKerr, J. S., Wexler, R. S., Mousa, S. A., Robinson, C. S., Wexler, E. J., Mohamed, S., Voss, M. E., Devenny, J. J., Czerniak, P. M., Gudzelak, A., Jr., and Slee, A. M. (1999) Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors, Anticancer Res 19, 959-968.spa
dc.relation.referencesCarron, C. P., Meyer, D. M., Pegg, J. A., Engleman, V. W., Nickols, M. A., Settle, S. L., Westlin, W. F., Ruminski, P. G., and Nickols, G. A. (1998) A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy, Cancer Res 58, 1930-1935.spa
dc.relation.referencesLode, H. N., Moehler, T., Xiang, R., Jonczyk, A., Gillies, S. D., Cheresh, D. A., and Reisfeld, R. A. (1999) Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases, Proc Natl Acad Sci U S A 96, 1591-1596.spa
dc.relation.referencesBoney, W., Hiran, F. Gillart, G. (2004) Protein disulfide isomerase, Biochemica biophysica acta 1699, 35.spa
dc.relation.referencesAppenzeller-Herzog, C., and Ellgaard, L. (2008) The human PDI family: versatility packed into a single fold, Biochim Biophys Acta 1783, 535-548.spa
dc.relation.referencesHatahet, F., and Ruddock, L. W. (2009) Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation, Antioxid Redox Signal 11, 2807-2850.spa
dc.relation.referencesGruber, C. W., Cemazar, M., Heras, B., Martin, J. L., and Craik, D. J. (2006) Protein disulfide isomerase: the structure of oxidative folding, Trends Biochem Sci 31, 455-464.spa
dc.relation.referencesTurano, C., Coppari, S., Altieri, F., and Ferraro, A. (2002) Proteins of the PDI family: unpredicted non-ER locations and functions, J Cell Physiol 193, 154-163.spa
dc.relation.referencesJordan, P. A., and Gibbins, J. M. (2006) Extracellular disulfide exchange and the regulation of cellular function, Antioxid Redox Signal 8, 312-324.spa
dc.relation.referencesTerada, K., Manchikalapudi, P., Noiva, R., Jauregui, H. O., Stockert, R. J., and Schilsky, M. L. (1995) Secretion, surface localization, turnover, and steady state expression of protein disulfide isomerase in rat hepatocytes, J Biol Chem 270, 20410-20416.spa
dc.relation.referencesTager, M., Kroning, H., Thiel, U., and Ansorge, S. (1997) Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells, Exp Hematol 25, 601-607.spa
dc.relation.referencesDesilva, M. G., Lu, J., Donadel, G., Modi, W. S., Xie, H., Notkins, A. L., and Lan, M. S. (1996) Characterization and chromosomal localization of a new protein disulfide isomerase, PDIp, highly expressed in human pancreas, DNA Cell Biol 15, 9-16.spa
dc.relation.referencesGoplen, D., Wang, J., Enger, P. O., Tysnes, B. B., Terzis, A. J., Laerum, O. D., and Bjerkvig, R. (2006) Protein disulfide isomerase expression is related to the invasive properties of malignant glioma, Cancer Res 66, 9895-9902.spa
dc.relation.referencesEssex, D. W., and Li, M. (2003) Redox control of platelet aggregation, Biochemistry 42, 129-136.spa
dc.relation.referencesEssex, D. W., Miller, A., Swiatkowska, M., and Feinman, R. D. (1999) Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin, Biochemistry 38, 10398-10405.spa
dc.relation.referencesGallina, A., Hanley, T. M., Mandel, R., Trahey, M., Broder, C. C., Viglianti, G. A., and Ryser, H. J. (2002) Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry, J Biol Chem 277, 50579-50588.spa
dc.relation.referencesAbell, B. A., and Brown, D. T. (1993) Sindbis virus membrane fusion is mediated by reduction of glycoprotein disulfide bridges at the cell surface, J Virol 67, 5496-5501.spa
dc.relation.referencesMarkovic, I., Pulyaeva, H., Sokoloff, A., and Chernomordik, L. V. (1998) Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates, J Cell Biol 143, 1155-1166.spa
dc.relation.referencesAbou-Jaoude, G., and Sureau, C. (2007) Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange, J Virol 81, 13057-13066.spa
dc.relation.referencesJain, S., McGinnes, L. W., and Morrison, T. G. (2009) Role of thiol/disulfide exchange in newcastle disease virus entry, J Virol 83, 241-249.spa
dc.relation.referencesMirazimi, A., and Svensson, L. (1998) Carbohydrates facilitate correct disulfide bond formation and folding of rotavirus VP7, J Virol 72, 3887-3892.spa
dc.relation.referencesChen, J. Z., Settembre, E. C., Aoki, S. T., Zhang, X., Bellamy, A. R., Dormitzer, P. R., Harrison, S. C., and Grigorieff, N. (2009) Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM, Proc Natl Acad Sci U S A 106, 10644-10648.spa
dc.relation.referencesPatton, J. T., Hua, J., and Mansell, E. A. (1993) Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4, J Virol 67, 4848-4855.spa
dc.relation.referencesLovat, P. E., Corazzari, M., Armstrong, J. L., Martin, S., Pagliarini, V., Hill, D., Brown, A. M., Piacentini, M., Birch-Machin, M. A., and Redfern, C. P. (2008) Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress, Cancer Res 68, 5363-5369.spa
dc.relation.referencesFonseca, C., Soiffer, R., Ho, V., Vanneman, M., Jinushi, M., Ritz, J., Neuberg, D., Stone, R., DeAngelo, D., and Dranoff, G. (2009) Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction, Blood 113, 1681-1688.spa
dc.relation.referencesHoffman, R., Furie, B., McGlave. . (2008) Hematology. Basic Principles and practice., Hematology 4 ed 63-68.spa
dc.relation.referencesArmstrong, S. A., and Look, A. T. (2005) Molecular genetics of acute lymphoblastic leukemia, J Clin Oncol 23, 6306-6315.spa
dc.relation.referencesAbbasi, S., Maleha, F., and Shobaki, M. (2013) Acute lymphoblastic leukemia experience: epidemiology and outcome of two different regimens, Mediterr J Hematol Infect Dis 5, e2013024.spa
dc.relation.referencesBennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R., and Sultan, C. (1981) The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations, Br J Haematol 47, 553-561.spa
dc.relation.referencesRavindranath, Y. (2003) Recent advances in pediatric acute lymphoblastic and myeloid leukemia, Curr Opin Oncol 15, 23-35.spa
dc.relation.referencesChan, K. W. (2002) Acute lymphoblastic leukemia, Curr Probl Pediatr Adolesc Health Care 32, 40-49.spa
dc.relation.referencesRedaelli, A., Laskin, B. L., Stephens, J. M., Botteman, M. F., and Pashos, C. L. (2005) A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL), Eur J Cancer Care (Engl) 14, 53-62.spa
dc.relation.referencesZiegler, D. S., Dalla Pozza, L., Waters, K. D., and Marshall, G. M. (2005) Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy, Med J Aust 182, 78-81.spa
dc.relation.referencesPiñeros, M., Pardo, C., Otero, J., Suarez, A., Vizcaino, M. (2008) Protocolo de vigilancia centinela en salud pública de las leucemias agudas pediátricas., Instituto Nacional de Salud, Ministerio de la Protección Social, Instituto Nacional de Cancerología 2008.spa
dc.relation.referencesRubnitz, J. E., and Pui, C. H. (2003) Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia, Cancer Treat Rev 29, 31-44.spa
dc.relation.referencesBelson, M., Kingsley, B., and Holmes, A. (2007) Risk factors for acute leukemia in children: a review, Environ Health Perspect 115, 138-145.spa
dc.relation.referencesPombo-de-Oliveira, M. S., and Koifman, S. (2006) Infant acute leukemia and maternal exposures during pregnancy, Cancer Epidemiol Biomarkers Prev 15, 2336-2341.spa
dc.relation.referencesSakajiri, S., Mori, K., Isobe, Y., Kawamata, N., and Oshimi, K. (2002) Epstein-Barr virus-associated T-cell acute lymphoblastic leukaemia, Br J Haematol 117, 127-129.spa
dc.relation.referencesSlater, D. N. (2002) The new World Health Organization classification of haematopoietic and lymphoid tumours: a dermatopathological perspective, Br J Dermatol 147, 633-639.spa
dc.relation.referencesBhatnagar, S., Chandra, J., and Narayan, S. (2002) Hematological changes and predictors of bone marrow recovery in patients with neutropenic episodes in acute lymphoblastic leukemia, J Trop Pediatr 48, 200-203.spa
dc.relation.referencesKuriyama, K. (2003) [FAB amd WHO classification of leukemia], Nihon Naika Gakkai Zasshi 92, 934-941.spa
dc.relation.referencesSwerdlow, S., campo, E., Harris, N. . (2009) WHO classification of tumor of hematopoietic and lymphoid tissues, IARC Press, 109-138.spa
dc.relation.referencesDock, G. e. a. (1904) Rabies virus vaccination in a patient with cervical carcinoma, Am J Med Sci, 127-563.spa
dc.relation.referencesDePace, N. (1912) Sulla scomparsa di un enorme cancro vegetante del collo dell’utero senza cura chirurgica, Ginecologia 9, 82-89.spa
dc.relation.referencesCalderón, M. N., Acosta, O., Guererro, C. A., Guaman, F. . (2008) Protein isulfide isomerase activity is involved in rotavirus entry to MA104 cells, Proceding of the Xiv International congres of virology Instambul, 1632-1664.spa
dc.relation.referencesGuo, W., and Giancotti, F. G. (2004) Integrin signalling during tumour progression, Nat Rev Mol Cell Biol 5, 816-826.spa
dc.relation.referencesArrigo, A. P. (2012) Editorial: heat shock proteins in cancer, Curr Mol Med 12, 1099-1101.spa
dc.relation.referencesSilva, E., Guerrero, C., Acosta, O. (2012) Potencial oncolitico del rotavirus en la linea celular de linfoma histiocitico humano U937, Tesis de Maestría en genética humana. Universidad Nacional de Colombia.spa
dc.relation.referencesAlfonso, E., Rodríguez, S. Guerrero, C. (2012) Interacción de las proteínas de choque termico Hsp90 y Hsp70 con aislamientos de rotavirus en las lineas celulares U937, Tesis de pregrado licenciatura en Biología. Universidad Distrital Frnsisco José de Caldas.spa
dc.relation.referencesGuerrero, R., Guerrero, C. (2012) Determinación del potencial oncolítico del rotavirus en la línea celular de cáncer de mieloma murino sp2/0-ag14, Tesis de Maestría en Bioquímica. Facultad de medicina. Universidad Nacional de Colombia.spa
dc.relation.referencesGuerrero, C. A., Santana, A. Y., and Acosta, O. (2010) Mouse intestinal villi as a model system for studies of rotavirus infection, J Virol Methods 168, 22-30.spa
dc.relation.referencesGuerrero, C. A., Torres, D. P., Garcia, L. L., Guerrero, R. A., and Acosta, O. (2014) N-Acetylcysteine treatment of rotavirus-associated diarrhea in children, Pharmacotherapy 34, e333-340.spa
dc.relation.referencesArnold, M., Patton, J. T., and McDonald, S. M. (2009) Culturing, storage, and quantification of rotaviruses, Curr Protoc Microbiol Chapter 15, Unit 15C 13.spa
dc.relation.referencesGroene, W. S., and Shaw, R. D. (1992) Psoralen preparation of antigenically intact noninfectious rotavirus particles, J Virol Methods 38, 93-102.spa
dc.relation.referencesBerry, M. J., and Samuel, C. E. (1982) Detection of subnanogram amounts of RNA in polyacrylamide gels in the presence and absence of protein by staining with silver, Anal Biochem 124, 180-184.spa
dc.relation.referencesJones, R. W., Ross, J., and Hoshino, Y. (2003) Identification of parental origin of cognate dsRNA genome segment(s) of rotavirus reassortants by constant denaturant gel electrophoresis, J Clin Virol 26, 347-354.spa
dc.relation.referencesWHO. World Health Organization. Expanded Programme on Immunization of the Department of Immunization, V. a. B. (2009) Manual of rotavirus detection and characterization methods, WHO Document Production Services, Geneva, Switzerland. WHO/IVB/08.17.spa
dc.relation.referencesCampbell, S. A., and Gromeier, M. (2005) Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells, Onkologie 28, 209-215.spa
dc.relation.referencesCampbell, S. A., and Gromeier, M. (2005) Oncolytic viruses for cancer therapy I. Cell-external factors: virus entry and receptor interaction, Onkologie 28, 144-149.spa
dc.relation.referencesCarreno-Torres, J. J., Gutierrez, M., Arias, C. F., Lopez, S., and Isa, P. (2010) Characterization of viroplasm formation during the early stages of rotavirus infection, Virol J 7, 350.spa
dc.relation.referencesEichwald, C., Rodriguez, J. F., and Burrone, O. R. (2004) Characterization of rotavirus NSP2/NSP5 interactions and the dynamics of viroplasm formation, J Gen Virol 85, 625-634.spa
dc.relation.referencesOffit, P. A., Clark, H. F., Taylor, A. H., Hess, R. G., Bachmann, P. A., and Plotkin, S. A. (1984) Rotavirus-specific antibodies in fetal bovine serum and commercial preparations of serum albumin, J Clin Microbiol 20, 266-270.spa
dc.relation.referencesSato, K., Inaba, Y., Tokuhisa, S., Miura, Y., Akashi, H., and Tanaka, Y. (1980) Antibodies against several viruses in sera from normal bovine fetuses and precolostral calves, Natl Inst Anim Health Q (Tokyo) 20, 77-78.spa
dc.relation.referencesEstes, M. K., Graham, D. Y., Gerba, C. P., and Smith, E. M. (1979) Simian rotavirus SA11 replication in cell cultures, J Virol 31, 810-815.spa
dc.relation.referencesChaibi, C., Cotte-Laffitte, J., Sandre, C., Esclatine, A., Servin, A. L., Quero, A. M., and Geniteau-Legendre, M. (2005) Rotavirus induces apoptosis in fully differentiated human intestinal Caco-2 cells, Virology 332, 480-490.spa
dc.relation.referencesBautista, D., Rodriguez, L. S., Franco, M. A., Angel, J., and Barreto, A. (2015) Caco-2 cells infected with rotavirus release extracellular vesicles that express markers of apoptotic bodies and exosomes, Cell Stress Chaperones 20, 697-708.spa
dc.relation.referencesPerez, J. F., Chemello, M. E., Liprandi, F., Ruiz, M. C., and Michelangeli, F. (1998) Oncosis in MA104 cells is induced by rotavirus infection through an increase in intracellular Ca2+ concentration, Virology 252, 17-27.spa
dc.relation.referencesHalasz, P., Holloway, G., and Coulson, B. S. (2010) Death mechanisms in epithelial cells following rotavirus infection, exposure to inactivated rotavirus or genome transfection, J Gen Virol 91, 2007-2018.spa
dc.relation.referencesHolloway, G., Johnson, R. I., Kang, Y., Dang, V. T., Stojanovski, D., and Coulson, B. S. (2015) Rotavirus NSP6 localizes to mitochondria via a predicted N-terminal a-helix, J Gen Virol 96, 3519-3524.spa
dc.relation.referencesBhowmick, R., Halder, U. C., Chattopadhyay, S., Chanda, S., Nandi, S., Bagchi, P., Nayak, M. K., Chakrabarti, O., Kobayashi, N., and Chawla-Sarkar, M. (2012) Rotaviral enterotoxin nonstructural protein 4 targets mitochondria for activation of apoptosis during infection, J Biol Chem 287, 35004-35020.spa
dc.relation.referencesMartin-Latil, S., Mousson, L., Autret, A., Colbere-Garapin, F., and Blondel, B. (2007) Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway, J Virol 81, 4457-4464.spa
dc.relation.referencesBhowmick, R., Halder, U. C., Chattopadhyay, S., Nayak, M. K., and Chawla-Sarkar, M. (2013) Rotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53, J Virol 87, 6840-6850.spa
dc.relation.referencesGuerrero, C. A., and Acosta, O. (2016) Inflammatory and oxidative stress in rotavirus infection, World J Virol 5, 38-62.spa
dc.relation.referencesGuerrero, C. A., and Acosta, O. (2016) Inflammatory and oxidative stress in rotavirus infection, World J Virol 5, 38-62.spa
dc.relation.referencesDutta, D., Bagchi, P., Chatterjee, A., Nayak, M. K., Mukherjee, A., Chattopadhyay, S., Nagashima, S., Kobayashi, N., Komoto, S., Taniguchi, K., and Chawla-Sarkar, M. (2009) The molecular chaperone heat shock protein-90 positively regulates rotavirus infectionx, Virology 391, 325-333.spa
dc.relation.referencesNomaguchi, M., Fujita, M., Miyazaki, Y., and Adachi, A. (2012) Viral tropism, Front Microbiol 3, 281.spa
dc.relation.referencesZhu, Y. Z., Cao, M. M., Wang, W. B., Wang, W., Ren, H., Zhao, P., and Qi, Z. T. (2012) Association of heat-shock protein 70 with lipid rafts is required for Japanese encephalitis virus infection in Huh7 cells, J Gen Virol 93, 61-71.spa
dc.relation.referencesCripe, T. P., Delos, S. E., Estes, P. A., and Garcea, R. L. (1995) In vivo and in vitro association of hsc70 with polyomavirus capsid proteins, J Virol 69, 7807-7813.spa
dc.relation.referencesChromy, L. R., Pipas, J. M., and Garcea, R. L. (2003) Chaperone-mediated in vitro assembly of Polyomavirus capsids, Proc Natl Acad Sci U S A 100, 10477-10482.spa
dc.relation.referencesNiewiarowska, J., D'Halluin, J. C., and Belin, M. T. (1992) Adenovirus capsid proteins interact with HSP70 proteins after penetration in human or rodent cells, Exp Cell Res 201, 408-416.spa
dc.relation.referencesFust, G., Beck, Z., Banhegyi, D., Kocsis, J., Biro, A., and Prohaszka, Z. (2005) Antibodies against heat shock proteins and cholesterol in HIV infection, Mol Immunol 42, 79-85.spa
dc.relation.referencesMcDonald, S. M., and Patton, J. T. (2011) Assortment and packaging of the segmented rotavirus genome, Trends Microbiol 19, 136-144.spa
dc.relation.referencesIturriza Gomara M, D. U. a. G. J. (2003) Molecular epidemiology of rotaviruses: genetic mechanisms associated with diversity., Perspectives in Medical Virology. Viral gastroenteritis. Desselberger U, Gray J, editors; Elsevier Science. 9, 27.spa
dc.relation.referencesYate., G. C. C. (2014) Distribución de genotipos de rotavirus del grupo a en once departamentos de Colombia posterior a la introducción de la vacuna anti-rotavirus, 2009 – 2013., Universidad Nacional de Colombia. Facultad de ciencias. Maestría en Microbiología. Bogotá, Colombia, 114.spa
dc.rightsDerechos reservados - Universidad Nacional de Colombiaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.spaAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.ddc610 - Medicina y saludspa
dc.subject.proposalRotavirusspa
dc.subject.proposalRotaviruseng
dc.subject.proposalOncolytic viruseseng
dc.subject.proposalVirus oncolíticosspa
dc.subject.proposalLeucemia linfoblástica agudaspa
dc.subject.proposalAcute lymphoblastic leukemiaeng
dc.subject.proposalheat shock proteinseng
dc.subject.proposalPDIspa
dc.subject.proposalIntegrina β3spa
dc.subject.proposalPDIeng
dc.subject.proposalIntegrin-β3eng
dc.subject.proposalProteínas de choque térmicospa
dc.titleCaracterización del potencial oncolítico del aislamiento rotaviral Wt1-5 en cultivos primarios de leucemia linfoblástica aguda de precursores Bspa
dc.title.alternativeCharacterization of the oncolytic potential of rotaviral isolate Wt1 -5 in primary cultures of precursor B-cell lymphoblastic leukemiaspa
dc.typeTrabajo de grado - Doctoradospa
dc.type.coarhttp://purl.org/coar/resource_type/c_db06spa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/doctoralThesisspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1049605017.2018.pdf
Tamaño:
9.57 MB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
3.8 KB
Formato:
Item-specific license agreed upon to submission
Descripción: